Identification of kidney injury released circulating osteopontin as causal agent of respiratory failure

Fatima Zohra Khamissi1, Liang Ning1, Eirini Kefaloyianni1

  • 1Washington University School in St. Louis School of Medicine, 660 S Euclid Avenue, St. Louis, MO 63110, USA.

Science Advances
|February 25, 2022
PubMed

Insights

Kidney injury can cause lung injury through a mediator called osteopontin (OPN). Inhibiting OPN prevents this secondary organ damage, offering potential new treatments for acute kidney injury and acute lung injury.

Area of Science:

  • Nephrology
  • Pulmonology
  • Immunology
  • Molecular Biology

Background:

  • Secondary organ injury following tissue damage is a significant clinical challenge.
  • The precise mechanisms and mediators driving interorgan crosstalk, such as acute kidney injury (AKI) leading to acute lung injury (ALI), remain incompletely understood.

Purpose of the Study:

  • To identify novel mediators involved in interorgan crosstalk using AKI-induced ALI as a model.
  • To elucidate the role of kidney-derived factors in triggering lung injury after AKI.

Main Methods:

  • Single-cell RNA sequencing of kidney and lung tissues in a mouse model of AKI.
  • Ligand-receptor pairing analysis to identify cross-organ signaling pathways.
  • Pharmacological and genetic inhibition of identified mediators.
  • Kidney transplantation experiments using wild-type and knockout mice.
  • Measurement of serum osteopontin levels in AKI patients.

Main Results:

  • Kidney-released circulating osteopontin (OPN) was identified as a key mediator of AKI-ALI.
  • OPN from kidney tubule cells induced lung endothelial leakage, inflammation, and respiratory failure.
  • Inhibition of OPN, either pharmacologically or genetically, ameliorated AKI-ALI.
  • Transplantation of ischemic kidneys lacking OPN did not induce ALI, confirming OPN's necessity.
  • Elevated serum OPN levels in AKI patients correlated with kidney injury severity.

Conclusions:

  • Kidney-derived OPN is a critical mediator of lung injury following AKI.
  • Targeting OPN presents a potential therapeutic strategy for AKI-ALI and multiorgan failure.
  • Cross-organ ligand-receptor analysis is a feasible approach for discovering interorgan communication mediators.

Related Concept Videos

Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
139
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
70
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
883
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
120
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
370
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
133